AI-generated summary
The authors report a placebo-controlled randomized trial of low-level laser therapy for oral mucositis in head and neck cancer patients receiving radiotherapy. At six weeks, the mean symptom score was higher, indicating worse outcomes, in the laser arm (33.2) than in the sham arm (27.4), and the trial was underpowered because recruitment targets were not met.
- Participants
- 87
- Who or what was studied
- Adult head and neck cancer patients aged 18 or older receiving irradiation of 60 Gy or more at nine NHS sites in England and Wales
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The trial lacked statistical power because it did not meet its recruitment target, and the authors state it was not definitive.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journalslibrary.nihr.ac.uk.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 3 J/cm2
- Power density (irradiance)
- 50 mW/cm2
- Power
- 75 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Oral mucositis, Randomized controlled trial, Photobiomodulation, Sham, Placebo-controlled, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.